Spectral AI’s (MDAI) Buy Rating Reaffirmed at HC Wainwright

Spectral AI (NASDAQ:MDAI – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities research analysts at HC Wainwright in a report issued on Tuesday,Benzinga reports. They presently have a $3.50 price target on the stock. HC Wainwright’s price target suggests a potential upside of 114.72% from the company’s current price. Spectral AI Stock […]

Leave a Reply

Your email address will not be published.

Previous post GDS (NASDAQ:GDS) Stock Rating Upgraded by Jefferies Financial Group
Next post Hims & Hers Health (NYSE:HIMS) Stock Price Expected to Rise, Bank of America Analyst Says